Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

This publication has 13 references indexed in Scilit:

• Cloning and Characterization of Scavidin, a Fusion Protein for the Targeted Delivery of Biotinylated Molecules
  Published by Elsevier ,2002
• Pretargeted adjuvant radioimmunotherapy with Yttrium-90-biotin in malignant glioma patients: A pilot study
  British Journal of Cancer, 2002
• Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridging.
  2000
• Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity
  Proceedings of the National Academy of Sciences, 2000
• Pretargeted Radioimmunotherapy (PRIT™) for Treatment of Non-Hodgkin's Lymphoma (NHL): Initial Phase I/II Study Results
  Cancer Biotherapy & Radiopharmaceuticals, 2000
• Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin
  European Journal of Nuclear Medicine and Molecular Imaging, 1999
• Combined treatment of advanced oropharyngeal cancer with external radiotherapy and three-step radioimmunotherapy.
  European Journal of Nuclear Medicine and Molecular Imaging, 1998
• Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha.
  1997
• The three-step pretargeting approach reduces the human anti-mouse antibody response in patients submitted to radioimmunoscintigraphy and radioimmunotherapy
  European Journal of Nuclear Medicine and Molecular Imaging, 1997
• The First Bagshawe lecture: Towards generating cytotoxic agents at cancer sites
  British Journal of Cancer, 1989